On Demand 2016 Literature Review

You can earn up to 6 AMA PRA Category 1 Credit(s)™

To help you stay up-to-date with the latest clinical developments in allergy and immunology, ACAAI continues its highly success Literature Review program. It’s a review of the most important, clinically focused literature of our specialty published between October 2015 and August 2016, with emphasis on clinical relevance. Faculty includes allergy/immunology training program directors and specialists in practice.

6.0 credits / $196 $77 members / $144 $115 non-members

Release Date: 12/01/2016

Expiration Date: 11/30/2019


The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning Objectives

  • Discuss recent developments in basic immunology in relation to allergic disorders.
  • Describe recent developments in infectious diseases, antimicrobials and vaccines.
  • Discuss recent developments in clinical immunology.
  • Better diagnose and manage asthma and COPD.
  • Discuss important scientific and clinical advances in the pathophysiology and treatment of urticaria, angioedema and other skin disorders.
  • Apply practical lessons learned from recent literature in pediatric allergy, asthma and immunology.
  • Identify new concepts in anaphylaxis, drug allergy and stinging insect hypersensitivity, as well as utilize clinically relevant findings in these areas.
  • Describe recent developments in immunotherapy.
  • Discuss recent developments in food allergy.
  • Better counsel patients on environmental factors that may impact respiratory and allergic disease and better recognize, diagnose and manage occupational allergic diseases.
  • Describe recent developments in rhinitis and sinusitis.
  • Apply practical lessons learned from recent literature in allergy, asthma and immunology.
Additional information

Mitchell H. Grayson, MD, FACAAI -- Supported/Contracted Research: Polyphor

Chitra Dinakar, MD, FACAAI -- Consultant/Advisor: Meda, Teva; Speaker: Boehringer Ingelheim, Teva

John M. Routes, MD, FACAAI -- Speaker: CSL Behring

Marc A. Riedl, MD, MS -- Consultant/Advisor: Baxter, Biocryst, CSL Behring, Grifols, Arrowhead, Ionis, Salix, Shire; Speaker: Baxter, CSL Behring, Dyax, Salix, Shire; Supported/ Contracted Research: Amgen, Biocryst, CSL Behring, Dyax, Ionis, Pharming, Shire

Anthony Montanaro, MD, FACAAI -- Supported/Contracted Research: Circassia, Merck, Novartis, Sunovion, Teva

David A. Khan, MD, FACAAI -- Speaker: Genentech

Harold S. Nelson, MD, FACAAI -- Consultant/Advisor: AstraZeneca, Circassia, Merck; Supported/Contracted Research: Circassia

Matthew Greenhawt, MD, MSc, MBA, FACAAI -- Consultant/Advisor: Nutricia, Monsanto, Nestle, Aimmune, Adamis Pharmaceutical, Kaleo Pharmaceutical, Introimmune Pharmaceutical, Speaker: Thermo Fisher Scientific

Mark S. Dykewicz, MD, FACAAI -- Consultant/Advisor: Merck

Anju T. Peters, MD -- Consultant/Advisor: Celgene, Greer; Speaker: Celgene, Greer; Supported/Contracted Research: Sanofi

The following have no financial relationship to disclose:

James T. Li, MD, PhD, FACAAI

John M. Kelso, MD, FACAAI

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance
Course opens: 
Course expires: 

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance


Please login or create an account to take this course.